The role of adipose tissue as an endocrine gland

Current Diabetes Reports

Volumn 5, Issue 5, 2005, Pages 317-319

  Hamdy, Osama ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADIPONECTIN; GLIBENCLAMIDE; INSULIN; LEPTIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ADIPOCYTE; ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETOGENESIS; GENETIC POLYMORPHISM; GLUCOSE TOLERANCE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPODYSTROPHY; LIPOSUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PROTEIN FUNCTION; RISK FACTOR; SUBCUTANEOUS FAT;

EID: 27744446896     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0086-0     Document Type: Note

References (15)

1. Aldahi W, Hamdy O: Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003, 3:293-298.
2. Yamauchi T, Kamon J, Ito Y, et al.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
3. Nishizawa H, Shimomura I, Kishida K, et al.: Androgens decrease plasma adiponectin, insulin sensitizing adipocyte derived protein. Diabetes 2002, 51:2734-2741.
4. Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
5. Hara K, Boutin P, Mori Y, Tobe K et al.: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
6. Monzillo LU, Hamdy O, Horton ES, et al.: Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003, 11:1048-1054.
7. Maeda N, Takahashi M, Funahashi T, et al.: PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes 2001, 50:2094-2099.
8. Schubert UK, Kaplan RC, Rood J, Scherer PE: The serum adiponectin response to rosiglitazone in type 2 diabetes is not affected by co-administration of glyburide or metformin. Diabetes 2003, 52(suppl 1):A543.
9. Ouchi N, Kihara S, Arita Y, et al.: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-Kappa B signaling through a camp dependent pathway. Circulation 2000, 102:1296-1301.
10. Yokota T, Oritani K, Takahashi I, et al.: Adiponectin, a new member of the family of soluble defense collagens, negatively reglated the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
11. Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J Biol Chem 2002, 277:37487-37491.
12. Wauters M, Considine RV, Yudkin JS, et al.: Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003, 35:92-96.
13. Peterson KF, Oral EA, Dufour S, et al.: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109:1345-1350.
14. Park KG, Park KS, Kim MJ, et al.: Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004, 63:135-142.
15. Hamdy O, Horton ES: Effect of weight reduction and moderate intensity exercise on TNF-alpba in obese subjects with and without diabetes. Diabetes 2004, 52(suppl 2):1726-P.